甲沙龙诱导的免疫血液溶解性贫血
Afoma Onyechi1, Jessica Ohemeng-Dapaah1, Rushin Patel1
1Department of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Journal of community hospital internal medicine perspectives
|October 23, 2023
概括
药物诱导的免疫血液溶解性贫血 (DIIHA) 是一种罕见的贫血类型. 肌肉松剂梅塔克萨隆可以引起DIIHA,呈黄和色尿液,随着治疗而消失.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学 是一个学科.
- 免疫学 免疫学 免疫学
背景情况:
- 药物诱导的免疫血液溶解性贫血 (DIIHA) 是一种不常见但严重的药物不良反应.
- 虽然β-乳酸胺抗生素经常涉及,但广泛的药物可以触发DIIHA.
- 准确诊断DIIHA可能具有挑战性,通常需要高度的怀疑指数.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170


